Allakos Inc. (ALLK) has announced positive phase II results from two additional chronic urticaria cohorts - patients with cholinergic urticaria and symptomatic dermographism.In the Cholinergic Urticaria Cohort, 9 of 11 patients achieved a response, and in the Symptomatic dermographism cohort, 7 of 10 patients achieved a response.Earlier this month, Allakos reported that 12 of 13 patients (92%) in ...
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.